DK1220676T3 - Forebyggelse af colorektal cancer - Google Patents

Forebyggelse af colorektal cancer

Info

Publication number
DK1220676T3
DK1220676T3 DK00962269T DK00962269T DK1220676T3 DK 1220676 T3 DK1220676 T3 DK 1220676T3 DK 00962269 T DK00962269 T DK 00962269T DK 00962269 T DK00962269 T DK 00962269T DK 1220676 T3 DK1220676 T3 DK 1220676T3
Authority
DK
Denmark
Prior art keywords
cancer
prostate
bladder
lung
prevention
Prior art date
Application number
DK00962269T
Other languages
Danish (da)
English (en)
Inventor
Hans Henrik Raskov
Original Assignee
Colotech As
Hans Henrik Raskov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colotech As, Hans Henrik Raskov filed Critical Colotech As
Application granted granted Critical
Publication of DK1220676T3 publication Critical patent/DK1220676T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK00962269T 1999-09-29 2000-09-29 Forebyggelse af colorektal cancer DK1220676T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901390 1999-09-29
PCT/DK2000/000546 WO2001022974A1 (en) 1999-09-29 2000-09-29 Prevention of colorectal cancer

Publications (1)

Publication Number Publication Date
DK1220676T3 true DK1220676T3 (da) 2005-09-05

Family

ID=8104340

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00962269T DK1220676T3 (da) 1999-09-29 2000-09-29 Forebyggelse af colorektal cancer

Country Status (13)

Country Link
US (1) US7851461B2 (pt)
EP (1) EP1220676B1 (pt)
AT (1) ATE294585T1 (pt)
AU (1) AU779996B2 (pt)
CA (1) CA2385755C (pt)
DE (1) DE60019947T2 (pt)
DK (1) DK1220676T3 (pt)
ES (1) ES2240159T3 (pt)
IS (1) IS2488B (pt)
NO (1) NO330061B1 (pt)
NZ (1) NZ517978A (pt)
PT (1) PT1220676E (pt)
WO (1) WO2001022974A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
WO2002080889A2 (en) * 2001-04-05 2002-10-17 Colotech A/S A combination dosage of a cyclooxygenase (cox) inhibitor, a vitamin d3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer
PT1220676E (pt) 1999-09-29 2005-08-31 Coloctech As Prevencao do cancro colorrectal
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
WO2011024208A1 (en) * 2009-08-24 2011-03-03 Colotech A/S Combination dosage form with acetylsalicylic acid, calcitriol and calcium
WO2011079249A2 (en) * 2009-12-23 2011-06-30 Glycomyr, Inc. Use of vitamin d glycosides and sulfates for treatment of disease
WO2012116699A1 (en) 2011-02-28 2012-09-07 Rigshospitalet Copenhagen University Hospital Active vitamin d or analogs thereof for use in in vivo or in vitro fertilization

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205025A1 (en) 1985-05-27 1986-12-17 Sumitomo Pharmaceuticals Company, Limited Fluorine derivatives of vitamin D3 and cell differentiation-inducing agents containing the same as an active ingredient
KR0144358B1 (ko) 1988-04-21 1998-07-15 피. 라이달 크리스텐슨 비타민 d 동족체
RU2139276C1 (ru) 1991-11-07 1999-10-10 Рисерч Инститьют фор Медсин энд Кемистри Производные амида витамина d и фармацевтическая композиция
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9226877D0 (en) 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Chemical compounds
GB9309422D0 (en) 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
GB9314400D0 (en) 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
GB9315253D0 (en) 1993-07-23 1993-09-08 Res Inst Medicine Chem Chemical compounds
DE4334154C2 (de) 1993-10-01 1997-05-22 Schering Ag 2-Halogeno-1,25-dihydroxy-cholecalciferole und pharmazeutische Zusammensetzungen
JPH11507669A (ja) 1995-06-12 1999-07-06 ジー.ディー.サール アンド カンパニー シクロオキシゲナーゼ−2インヒビターとロイコトリエンb▲下4▼受容体アンタゴニストの組合せによる炎症と炎症関連疾患の治療
US5948443A (en) 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5770215A (en) * 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition
PT1220676E (pt) 1999-09-29 2005-08-31 Coloctech As Prevencao do cancro colorrectal

Also Published As

Publication number Publication date
NZ517978A (en) 2003-11-28
PT1220676E (pt) 2005-08-31
DE60019947T2 (de) 2006-02-02
ES2240159T3 (es) 2005-10-16
NO330061B1 (no) 2011-02-14
DE60019947D1 (de) 2005-06-09
US20040116393A1 (en) 2004-06-17
NO20021437L (no) 2002-05-24
WO2001022974A1 (en) 2001-04-05
US7851461B2 (en) 2010-12-14
ATE294585T1 (de) 2005-05-15
AU779996B2 (en) 2005-02-24
EP1220676B1 (en) 2005-05-04
CA2385755A1 (en) 2001-04-05
AU7406300A (en) 2001-04-30
IS6317A (is) 2002-03-20
IS2488B (is) 2008-12-15
CA2385755C (en) 2007-02-06
NO20021437D0 (no) 2002-03-22
EP1220676A1 (en) 2002-07-10

Similar Documents

Publication Publication Date Title
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
AR109263A2 (es) Composición que comprende moxidectina
BRPI0508333A (pt) uso de um composto de vitamina d, método de prevenir e/ou tratar cistite intersticial, formulação farmacêutica, composto de vitamina d, e, kit
DK1220676T3 (da) Forebyggelse af colorektal cancer
BRPI0518619A2 (pt) mÉtodo de tratar cÂncer em um mamÍfero, combinaÇço farmacÊutica, uso de uma composiÇço ou combinaÇço farmacÊutica e composiÇço imunogÊnica
EA200801731A1 (ru) Составы и способы лечения тробмоцитемии
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
BRPI0415232A (pt) uso de xenÈnio com hipotermia para tratar asfixia neonatal
WO2005105135A8 (en) Il-6 for therapy or prevention of chemotherapy-induced neuropathy
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
DK1389122T3 (da) Forebyggelse af epitelcancer
EA200801890A1 (ru) Средство для лечения шума в ушах
MXPA05009849A (es) Terapia combinada que comprende nemorubicina y un inhibidor de la ciclooxigenasa-2.
DE60309926D1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
DK1490049T3 (da) Citalopram til behandling af forhöjet blodtryk
DK1962822T3 (da) Terapi af maligne neoplasier
DK1399143T3 (da) Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni
CL2004000633A1 (es) Compuestos copolimeros, composicion farmaceutica que los contiene y procedimiento de preparacion, utiles en el tratamiento de enfermedades metabolicas oseas.
CL2007003284A1 (es) Composicion farmaceutica que comprende una asociacion de i) ciclobenzaprina, ii) aceclofenaco y opcionalmente iii) excipientes; y su uso para el tratamiento de enfermedades musculares dolorosas.
GT200400014A (es) Metodo de tratamiento con nelfinavir
PL1700597T3 (pl) Kompozycja farmaceutyczna do podawania na skórę, zawierająca łącznie ubidekarenon, despantenol oraz chlorheksydynę lub jej farmakologicznie dopuszczalną sól